LEXICON PHARMACEUTICALS, INC. Cost of Revenue
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Cost of Revenue of $39.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- LEXICON PHARMACEUTICALS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $39.00K, a 18.18% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $108.00K, a 260.00% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $201.00K, a 42.24% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $10.00K, a 85.92% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. cost of goods and services sold for fiscal 2025 was $274.00K, a 55.52% decline from fiscal 2024.
- LEXICON PHARMACEUTICALS, INC. cost of goods and services sold for fiscal 2024 was $616.00K, a 624.71% increase from fiscal 2023.
- LEXICON PHARMACEUTICALS, INC. cost of goods and services sold for fiscal 2023 was $85.00K.
- LEXICON PHARMACEUTICALS, INC. cost of goods and services sold for fiscal 2022 was $0.00.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $39.00K 10-Q · filed 2026-08-06 | $147.00K 10-Q · filed 2026-08-06 | $348.00K derived: sum of 3 quarters · filed 2026-08-06 | $358.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $108.00K 10-Q · filed 2026-05-07 | $309.00K derived: sum of 2 quarters · filed 2026-05-07 | $319.00K derived: sum of 3 quarters · filed 2026-05-07 | $352.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $211.00K derived: sum of 2 quarters · filed 2026-03-05 | $244.00K derived: sum of 3 quarters · filed 2026-08-06 | $274.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $10.00K 10-Q · filed 2025-11-06 | $43.00K derived: sum of 2 quarters · filed 2026-08-06 | $73.00K 10-Q · filed 2025-11-06 | $421.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $33.00K 10-Q · filed 2026-08-06 | $63.00K 10-Q · filed 2026-08-06 | $411.00K derived: sum of 3 quarters · filed 2026-08-06 | $482.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $30.00K 10-Q · filed 2026-05-07 | $378.00K derived: sum of 2 quarters · filed 2026-05-07 | $449.00K derived: sum of 3 quarters · filed 2026-05-07 | $615.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $348.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $419.00K derived: sum of 2 quarters · filed 2026-03-05 | $585.00K derived: sum of 3 quarters · filed 2026-03-05 | $616.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $71.00K 10-Q · filed 2025-11-06 | $237.00K derived: sum of 2 quarters · filed 2025-11-06 | $268.00K 10-Q · filed 2025-11-06 | $338.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | $166.00K 10-Q · filed 2025-08-06 | $197.00K 10-Q · filed 2025-08-06 | $267.00K derived: sum of 3 quarters · filed 2026-03-05 | $274.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | $31.00K 10-Q · filed 2025-05-14 | $101.00K derived: sum of 2 quarters · filed 2026-03-05 | $108.00K derived: sum of 3 quarters · filed 2026-03-05 | $116.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $77.00K derived: sum of 2 quarters · filed 2026-03-05 | $85.00K derived: sum of 3 quarters · filed 2026-03-05 | $85.00K 10-K · filed 2026-03-05 |
| 2023-09-30 | $7.00K 10-Q · filed 2024-11-13 | $15.00K derived: sum of 2 quarters · filed 2024-11-13 | $15.00K 10-Q · filed 2024-11-13 | $15.00K derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-06-30 | $8.00K 10-Q · filed 2024-08-02 | $8.00K 10-Q · filed 2024-08-02 | $8.00K derived: sum of 3 quarters · filed 2025-03-07 | $8.00K derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 2 quarters · filed 2025-03-07 | $0.00 derived: sum of 3 quarters · filed 2025-03-07 | $0.00 derived: sum of 4 quarters · filed 2025-03-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $0.00 derived: sum of 2 quarters · filed 2025-03-07 | $0.00 derived: sum of 3 quarters · filed 2025-03-07 | $0.00 10-K · filed 2025-03-07 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $0.00 derived: sum of 2 quarters · filed 2024-03-25 | $0.00 derived: sum of 3 quarters · filed 2024-03-25 | $0.00 10-K · filed 2024-03-25 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | $0.00 derived: sum of 3 quarters · filed 2023-03-03 | $633.00K derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-03 | $633.00K derived: sum of 3 quarters · filed 2023-03-03 | $1.36M derived: sum of 4 quarters · filed 2023-03-03 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $633.00K derived: sum of 2 quarters · filed 2023-03-03 | $1.36M derived: sum of 3 quarters · filed 2023-03-03 | $1.93M 10-K · filed 2023-03-03 |
| 2020-09-30 | $633.00K 10-Q · filed 2021-11-09 | $1.36M derived: sum of 2 quarters · filed 2021-11-09 | $1.93M 10-Q · filed 2021-11-09 | $2.70M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $728.00K 10-Q · filed 2021-08-06 | $1.30M 10-Q · filed 2021-08-06 | $2.07M derived: sum of 3 quarters · filed 2022-03-10 | $2.65M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | $568.00K 10-Q · filed 2021-05-06 | $1.34M derived: sum of 2 quarters · filed 2022-03-10 | $1.92M derived: sum of 3 quarters · filed 2022-03-10 | $3.25M derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $774.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $1.35M derived: sum of 2 quarters · filed 2022-03-10 | $2.68M derived: sum of 3 quarters · filed 2022-03-10 | $3.23M 10-K · filed 2022-03-10 |
| 2019-09-30 | $577.00K 10-Q · filed 2020-10-30 | $1.90M derived: sum of 2 quarters · filed 2020-10-30 | $2.46M 10-Q · filed 2020-10-30 | $3.03M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $1.33M 10-Q · filed 2020-07-29 | $1.88M 10-Q · filed 2020-07-29 | $2.45M derived: sum of 3 quarters · filed 2021-03-12 | $3.00M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $553.00K 10-Q · filed 2020-04-27 | $1.12M derived: sum of 2 quarters · filed 2021-03-12 | $1.67M derived: sum of 3 quarters · filed 2021-03-12 | $2.51M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $569.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.12M derived: sum of 2 quarters · filed 2021-03-12 | $1.96M derived: sum of 3 quarters · filed 2021-03-12 | $2.49M 10-K · filed 2021-03-12 |
| 2018-09-30 | $551.00K 10-Q · filed 2019-11-07 | $1.39M derived: sum of 2 quarters · filed 2019-11-07 | $1.92M 10-Q · filed 2019-11-07 | $2.46M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $838.00K 10-Q · filed 2019-08-01 | $1.37M 10-Q · filed 2019-08-01 | $1.91M derived: sum of 3 quarters · filed 2020-03-12 | $2.51M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $533.00K 10-Q · filed 2019-05-01 | $1.07M derived: sum of 2 quarters · filed 2020-03-12 | $1.67M derived: sum of 3 quarters · filed 2020-03-12 | $2.21M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $538.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.14M derived: sum of 2 quarters · filed 2020-03-12 | $1.67M derived: sum of 3 quarters · filed 2020-03-12 | $1.90M 10-K · filed 2020-03-12 |
| 2017-09-30 | $599.00K 10-Q · filed 2018-11-01 | $1.14M derived: sum of 2 quarters · filed 2018-11-01 | $1.36M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $537.00K 10-Q · filed 2018-07-30 | $762.00K 10-Q · filed 2018-07-30 | ||
| 2016-12-31 | $0.00 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |